Your browser doesn't support javascript.
loading
A Knock-In Mouse Model of Thymoma With the GTF2I L424H Mutation.
He, Yongfeng; Kim, In-Kyu; Bian, Jing; Polyzos, Alexander; Di Giammartino, Dafne Campigli; Zhang, Yu-Wen; Luo, Ji; Hernandez, Maria O; Kedei, Noemi; Cam, Maggie; Borczuk, Alain C; Lee, Trevor; Han, Yumin; Conner, Elizabeth A; Wong, Madeline; Tillo, Desiree C; Umemura, Shigeki; Chen, Vincent; Ruan, Lydia; White, Jessica B; Miranda, Ileana C; Awasthi, Parirokh P; Altorki, Nasser K; Divakar, Prajan; Elemento, Olivier; Apostolou, Effie; Giaccone, Giuseppe.
Afiliação
  • He Y; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, New York.
  • Kim IK; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
  • Bian J; CCR Collaborative Bioinformatics Resource, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Polyzos A; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, New York.
  • Di Giammartino DC; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, New York.
  • Zhang YW; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia; New address: Department of Cell Biology, University of Virginia, School of Medicine, Charlottesville, Virginia.
  • Luo J; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Hernandez MO; Collaborative Protein Technology Resource, Office of Science and Technology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Kedei N; Collaborative Protein Technology Resource, Office of Science and Technology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Cam M; CCR Collaborative Bioinformatics Resource, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Borczuk AC; Department of Pathology, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, New York; New address: Department of Pathology, Northwell Health, Greenvale, New York.
  • Lee T; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, New York.
  • Han Y; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, New York.
  • Conner EA; CCR Genomics Core, National Cancer Institute, Bethesda, Maryland.
  • Wong M; CCR Genomics Core, National Cancer Institute, Bethesda, Maryland.
  • Tillo DC; CCR Genomics Core, National Cancer Institute, Bethesda, Maryland.
  • Umemura S; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
  • Chen V; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
  • Ruan L; CCR Collaborative Bioinformatics Resource, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • White JB; Caryl and Israel Englander Institute for Precision Medicine, New York-Presbyterian Hospital, Weill Cornell Medicine, New York, New York.
  • Miranda IC; Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, and The Rockefeller University, New York, New York.
  • Awasthi PP; Frederick National Laboratory for Cancer Research, Laboratory Animal Sciences, Mouse Modeling & Cryopreservation, National Cancer Institute, Frederick, Maryland.
  • Altorki NK; Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York.
  • Divakar P; NanoString Technologies Inc., Seattle, Washington.
  • Elemento O; Caryl and Israel Englander Institute for Precision Medicine, New York-Presbyterian Hospital, Weill Cornell Medicine, New York, New York.
  • Apostolou E; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, New York.
  • Giaccone G; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, New York; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia. Electronic address: gig4001@med.cornell.edu.
J Thorac Oncol ; 17(12): 1375-1386, 2022 12.
Article em En | MEDLINE | ID: mdl-36049655
ABSTRACT

INTRODUCTION:

The pathogenesis of thymic epithelial tumors remains largely unknown. We previously identified GTF2I L424H as the most frequently recurrent mutation in thymic epithelial tumors. Nevertheless, the precise role of this mutation in tumorigenesis of thymic epithelial cells is unclear.

METHODS:

To investigate the role of GTF2I L424H mutation in thymic epithelial cells in vivo, we generated and characterized a mouse model in which the Gtf2i L424H mutation was conditionally knocked-in in the Foxn1+ thymic epithelial cells. Digital spatial profiling was performed on thymomas and normal thymic tissues with GeoMx-mouse whole transcriptome atlas. Immunohistochemistry staining was performed using both mouse tissues and human thymic epithelial tumors.

RESULTS:

We observed that the Gtf2i mutation impairs development of the thymic medulla and maturation of medullary thymic epithelial cells in young mice and causes tumor formation in the thymus of aged mice. Cell cycle-related pathways, such as E2F targets and MYC targets, are enriched in the tumor epithelial cells. Results of gene set variation assay analysis revealed that gene signatures of cortical thymic epithelial cells and thymic epithelial progenitor cells are also enriched in the thymomas of the knock-in mice, which mirrors the human counterparts in The Cancer Genome Atlas database. Immunohistochemistry results revealed similar expression pattern of epithelial cell markers between mouse and human thymomas.

CONCLUSIONS:

We have developed and characterized a novel thymoma mouse model. This study improves knowledge of the molecular drivers in thymic epithelial cells and provides a tool for further study of the biology of thymic epithelial tumors and for development of novel therapies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Timoma / Neoplasias do Timo / Neoplasias Epiteliais e Glandulares / Fatores de Transcrição TFII / Fatores de Transcrição TFIII Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Timoma / Neoplasias do Timo / Neoplasias Epiteliais e Glandulares / Fatores de Transcrição TFII / Fatores de Transcrição TFIII Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2022 Tipo de documento: Article